PLRX
Pliant Therapeutics Inc
NASDAQ · Pharmaceuticals
$1.14
+0.05 (+4.59%)
Open$1.12
Previous Close$1.09
Day High$1.19
Day Low$1.11
52W High$21.67
52W Low$11.18
Volume—
Avg Volume485.7K
Market Cap70.05M
P/E Ratio19.38
EPS$0.84
SectorPharmaceuticals
Analyst Ratings
Sell
12 analysts
Price Target
+1,398.2% upside
Current
$1.14
$1.14
Target
$17.08
$17.08
$13.48
$17.08 avg
$25.30
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.16M | 13.79M | 14.54M |
| Net Income | 3.08M | 2.65M | 3.08M |
| Profit Margin | 20.3% | 19.2% | 21.2% |
| EBITDA | 5.59M | 4.59M | 4.96M |
| Free Cash Flow | 2.06M | 2.45M | 2.36M |
| Rev Growth | +19.0% | -9.0% | -2.1% |
| Debt/Equity | 0.34 | 0.31 | 0.34 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |